BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 25730798)

  • 1. An extract of Perilla stem inhibits Src homology phosphatase-1 (SHP)-1 and influences insulin signaling.
    Peng L; Lei Z; Xiao-na X; Deli W; Jing S; Yong-sen W; Zhi W; Shu X; Jun-feng M; Wan-nan L; Xue-qi F
    Pak J Pharm Sci; 2015 Mar; 28(2):421-4. PubMed ID: 25730798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of the protein tyrosine phosphatase SHP-1 (Src homology phosphatase-1) in the regulation of interleukin-3-induced survival, proliferation and signalling.
    Paling NR; Welham MJ
    Biochem J; 2002 Dec; 368(Pt 3):885-94. PubMed ID: 12220225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Shp-2 tyrosine phosphatase activates the Src tyrosine kinase by a non-enzymatic mechanism.
    Walter AO; Peng ZY; Cartwright CA
    Oncogene; 1999 Mar; 18(11):1911-20. PubMed ID: 10208413
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The critical role of SRC homology domain 2-containing tyrosine phosphatase-1 in recombinant human erythropoietin hyporesponsive anemia in chronic hemodialysis patients.
    Akagi S; Ichikawa H; Okada T; Sarai A; Sugimoto T; Morimoto H; Kihara T; Yano A; Nakao K; Nagake Y; Wada J; Makino H
    J Am Soc Nephrol; 2004 Dec; 15(12):3215-24. PubMed ID: 15579525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tyrosine phosphatase SHP-2 is required for mediating phosphatidylinositol 3-kinase/Akt activation by growth factors.
    Wu CJ; O'Rourke DM; Feng GS; Johnson GR; Wang Q; Greene MI
    Oncogene; 2001 Sep; 20(42):6018-25. PubMed ID: 11593409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Specificity of the SH2 domains of SHP-1 in the interaction with the immunoreceptor tyrosine-based inhibitory motif-bearing receptor gp49B.
    Wang LL; Blasioli J; Plas DR; Thomas ML; Yokoyama WM
    J Immunol; 1999 Feb; 162(3):1318-23. PubMed ID: 9973385
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interaction of the tyrosine phosphatase SHP-2 with Gab2 regulates Rho-dependent activation of the c-fos serum response element by interleukin-2.
    Arnaud M; Mzali R; Gesbert F; Crouin C; Guenzi C; Vermot-Desroches C; Wijdenes J; Courtois G; Bernard O; Bertoglio J
    Biochem J; 2004 Sep; 382(Pt 2):545-56. PubMed ID: 15170389
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shp-2 tyrosine phosphatase: signaling one cell or many.
    Feng GS
    Exp Cell Res; 1999 Nov; 253(1):47-54. PubMed ID: 10579910
    [TBL] [Abstract][Full Text] [Related]  

  • 9. B cell antigen receptor (BCR)-mediated formation of a SHP-2-pp120 complex and its inhibition by Fc gamma RIIB1-BCR coligation.
    Nakamura K; Cambier JC
    J Immunol; 1998 Jul; 161(2):684-91. PubMed ID: 9670943
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A SHPing tale: perspectives on the regulation of SHP-1 and SHP-2 tyrosine phosphatases by the C-terminal tail.
    Poole AW; Jones ML
    Cell Signal; 2005 Nov; 17(11):1323-32. PubMed ID: 16084691
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SH2-Containing protein tyrosine phosphatase-1 (SHP-1) association with Jak2 in UT-7/Epo cells.
    Wu DW; Stark KC; Dunnington D; Dillon SB; Yi T; Jones C; Pelus LM
    Blood Cells Mol Dis; 2000 Feb; 26(1):15-24. PubMed ID: 10772872
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SH2 domain containing protein tyrosine phosphatase 2 regulates concanavalin A-dependent secretion and activation of matrix metalloproteinase 2 via the extracellular signal-regulated kinase and p38 pathways.
    Ruhul Amin AR; Oo ML; Senga T; Suzuki N; Feng GS; Hamaguchi M
    Cancer Res; 2003 Oct; 63(19):6334-9. PubMed ID: 14559821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SHP-1 dephosphorylates 3BP2 and potentially downregulates 3BP2-mediated T cell antigen receptor signaling.
    Yu Z; Maoui M; Zhao ZJ; Li Y; Shen SH
    FEBS J; 2006 May; 273(10):2195-205. PubMed ID: 16649996
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of SHP-1 induced by hyperglycemia prevents insulin actions in podocytes.
    Drapeau N; Lizotte F; Denhez B; Guay A; Kennedy CR; Geraldes P
    Am J Physiol Endocrinol Metab; 2013 Jun; 304(11):E1188-98. PubMed ID: 23531619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple in vivo phosphorylated tyrosine phosphatase SHP-2 engages binding to Grb2 via tyrosine 584.
    Vogel W; Ullrich A
    Cell Growth Differ; 1996 Dec; 7(12):1589-97. PubMed ID: 8959326
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Src-homology domain 2-bearing protein tyrosine phosphatase-1 inhibits antigen receptor-induced apoptosis of activated peripheral T cells.
    Zhang J; Somani AK; Watt S; Mills GB; Siminovitch KA
    J Immunol; 1999 Jun; 162(11):6359-67. PubMed ID: 10352248
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Roles of the SHP-1 tyrosine phosphatase in the negative regulation of cell signalling.
    Zhang J; Somani AK; Siminovitch KA
    Semin Immunol; 2000 Aug; 12(4):361-78. PubMed ID: 10995583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine.
    Okazaki T; Maeda A; Nishimura H; Kurosaki T; Honjo T
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13866-71. PubMed ID: 11698646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oxidation sensitivity of the catalytic cysteine of the protein-tyrosine phosphatases SHP-1 and SHP-2.
    Weibrecht I; Böhmer SA; Dagnell M; Kappert K; Ostman A; Böhmer FD
    Free Radic Biol Med; 2007 Jul; 43(1):100-10. PubMed ID: 17561098
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting SHP-1, 2 and SHIP Pathways: A Novel Strategy for Cancer Treatment?
    Dempke WCM; Uciechowski P; Fenchel K; Chevassut T
    Oncology; 2018; 95(5):257-269. PubMed ID: 29925063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.